polatuzumab vedotin,vedolizumab,bendamustine,rituximab
takeda,teva,roche
['lymphoma', ' vedo', 'bendamustine', 'polatuzumab', 'ritux']
. dr. matthew matasar ( ) &amp; colleagues present polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large b-cell lymphoma... at #ash22. 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.